What Analysts Are Saying About Vertex Pharmaceuticals Stock
What Analysts Are Saying About Vertex Pharmaceuticals Stock
分析师对福泰制药股票的看法
Breaking Down Analyst Ratings: A Detailed Examination...15 analysts have expressed a variety of opinions on Vertex Pharmaceuticals (NASDAQ:VRTX) over the past quarter, offering a diverse set of opinions from bullish to bearish.
在过去的一个季度中，有15名分析师对福泰制药（纳斯达克：VRTX）发表了各种观点，提供了从看好到看淡的多样化观点。
The table below provides a snapshot of their recent ratings, showcasing how sentiments have evolved over the past 30 days and comparing them to the preceding months.
下表提供了他们最近的评级快照，展示了情绪在过去30天中的演变情况，并将其与之前的月份进行比较。
The 12-month price targets assessed by analysts reveal further insights, featuring an average target of $500.53, a high estimate of $600.00, and a low estimate of $376.00. Witnessing a positive shift, the current average has risen by 8.29% from the previous average price target of $462.20.
分析师评估的12个月价格目标揭示了更多见解，平均目标为500.53美元，高估为600.00美元，低估为376.00美元。目前的平均目标已经出现正面变化，比上一次的平均价格目标462.20美元上涨了8.29%。
Breaking Down Analyst Ratings: A Detailed Examination...
分析师评级分析...
登录免费看全文
登录/注册
资讯热榜
更新时间